In late December 2019, a Chinese health commission reported a cluster of pneumonia cases in Wuhan. A few weeks later, when the first case of COVID-19 appeared in the US, federal, state, and local governments scrambled to implement defensive measures, including a multitude of relaxed reimbursement rules to ensure access to care during the outbreak. Nine months later we are still dealing with the impact and aftermath of the public health emergency.
In this session, Andrea clarifies the coronavirus-related DME billing modifications in effect and provides guidance for returning to normal as temporary regulations expire. Updates affecting DME operations include:
• Telehealth visits to supporting medical necessity.
• Oxygen coverage for acute diagnoses.
• CMN waivers for oxygen and infusion policies.
• Expanded patient access to respiratory and infusion therapy.
• Increased access to multi-function ventilators.
• Audits and enrollment.
• Signature requirements.